These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10891808)

  • 1. [Pharmacologic constraints imposed by the blood-brain barrier: the example of multiple sclerosis].
    Jolliet P
    Rev Neurol (Paris); 2000 Jul; 156(6-7):681-3. PubMed ID: 10891808
    [No Abstract]   [Full Text] [Related]  

  • 2. Quinpramine: revival of old anti-inflammatory principles in multiple sclerosis?
    Haghikia A; Gold R
    Exp Neurol; 2009 Jun; 217(2):240-1. PubMed ID: 19361499
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucocorticosteroid therapy for multiple sclerosis: a critical review.
    Andersson PB; Goodkin DE
    J Neurol Sci; 1998 Sep; 160(1):16-25. PubMed ID: 9804112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid and type 1 interferon interactions at the blood-brain barrier: relevance for drug therapies for multiple sclerosis.
    Gaillard PJ; van Der Meide PH; de Boer AG; Breimer DD
    Neuroreport; 2001 Jul; 12(10):2189-93. PubMed ID: 11447332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conference reports].
    Pelletier J
    Rev Neurol (Paris); 2000 Jul; 156(6-7):684-5. PubMed ID: 10891809
    [No Abstract]   [Full Text] [Related]  

  • 6. [New methods of drug delivery through the blood brain barrier].
    Bruhn C
    Dtsch Med Wochenschr; 2012 May; 137(21):p18. PubMed ID: 22622506
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunosuppressive therapy].
    Schumacher K; Gross R
    Internist (Berl); 1984 Jan; 25(1):51-9. PubMed ID: 6370894
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic problems in disseminated encephalomyelitis (multiple sclerosis)].
    Payk TR
    Ther Ggw; 1973 Mar; 112(3):349-50. PubMed ID: 4573496
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM; Gold R; Lühder F
    Expert Rev Neurother; 2006 Nov; 6(11):1657-70. PubMed ID: 17144780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple sclerosis].
    Offenhäusser M; Martin R
    Med Monatsschr Pharm; 1997 Jun; 20(6):149-57. PubMed ID: 9289627
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
    Weiner HL
    Arch Neurol; 2004 Oct; 61(10):1613-5. PubMed ID: 15477521
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental methods in the treatment of multiple sclerosis--new possibilities and hopes].
    Szczepanik M; Tutaj M; Filipczak-Bryniarska I; Bryniarski K
    Przegl Lek; 2005; 62(2):115-8. PubMed ID: 16095157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of multiple sclerosis and other autoimmune diseases with cladribine.
    Beutler E; Sipe J; Romine J; McMillan R; Zyroff J; Koziol J
    Semin Hematol; 1996 Jan; 33(1 Suppl 1):45-52. PubMed ID: 8714617
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug profile. Prednisolone].
    Hinz B; Schröder H
    Dtsch Med Wochenschr; 1998 Jul; 123(31-32):943-4. PubMed ID: 9721570
    [No Abstract]   [Full Text] [Related]  

  • 15. [Multiple sclerosis: from immunopathogenesis to disease management].
    Nervenarzt; 1996 Dec; 67(12 Suppl Von Der Im):1-8. PubMed ID: 9403091
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of multiple courses of antenatal corticosteroids on blood-brain barrier permeability in the ovine fetus.
    Sadowska GB; Patlak CS; Petersson KH; Stonestreet BS
    J Soc Gynecol Investig; 2006 May; 13(4):248-55. PubMed ID: 16697940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New treatments for multiple sclerosis].
    Masdeu JC
    Rev Neurol; 1996 Jun; 24(130):708-11. PubMed ID: 8653621
    [No Abstract]   [Full Text] [Related]  

  • 18. XToll, a recombinant chaperonin 10 as an anti-inflammatory immunomodulator.
    van Eden W
    Curr Opin Investig Drugs; 2008 May; 9(5):523-33. PubMed ID: 18465663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood-brain barrier (BBB) permeability in multiple sclerosis.
    Rafałowska J; Krajewski S; Dolińska E
    Neuropatol Pol; 1990; 28(1-2):41-54. PubMed ID: 2097537
    [No Abstract]   [Full Text] [Related]  

  • 20. [Autoimmune diseases and immunosuppressive therapy].
    Pinther A
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):177-81. PubMed ID: 4913085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.